GSA Capital Partners’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-25,908
| Closed | -$437K | – | 1642 |
|
|
2021
Q4 | $437K | Buy |
25,908
+7,360
| +40% | +$124K | 0.05% | 687 |
|
|
2021
Q3 | $344K | Buy |
18,548
+10,223
| +123% | +$190K | 0.04% | 926 |
|
|
2021
Q2 | $198K | Buy |
8,325
+914
| +12% | +$21.7K | 0.02% | 1188 |
|
|
2021
Q1 | $190K | Sell |
7,411
-3,530
| -32% | -$90.5K | 0.03% | 921 |
|
|
2020
Q4 | $253K | Buy |
10,941
+6,246
| +133% | +$144K | 0.04% | 837 |
|
|
2020
Q3 | $113K | Buy |
4,695
+1,144
| +32% | +$27.5K | 0.02% | 1114 |
|
|
2020
Q2 | $76K | Buy |
+3,551
| New | +$76K | 0.04% | 515 |
|